Held and Distributed by the WHO International Laboratories for Biological Standards
WHO International Biological Reference Preparations
PREPARATION STANDARD MATERIAL HELD AT CODE WHO/BS
DOCUMENT
whqlibdoc.who.int/hq/2008/WHO_BS_08.2086_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2086_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2086_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2086_eng.pdf Acellular pertussis vaccine for potency assay by modified mou
challenge test, Lyophilized, 34 IU / ampoule
Vaccine JNIH-308.2086
1st International Standard, 2008
NIBSC
Activin A, human, recombinant, Lyophilized, 5 units / ampoule.Recombinant hormone
91/62698.1882
1st Reference Reagent, 1998NIBSC
whqlibdoc.who.int/hq/2006/WHO_BS_06.2044_eng.pdf
whqlibdoc.who.int/hq/2006/WHO_BS_06.2044_eng.pdf
whqlibdoc.who.int/hq/2006/WHO_BS_06.2044_eng.pdf
whqlibdoc.who.int/hq/2006/WHO_BS_06.2044_eng.pdf Alpha-1-antitrypsin, Lyophilized, 243 nmoles / ampoule for total
protein and antigen equivalent to 12.4 mg for plasma derived products.
Human plasma05/16206.2044
1st International Standard, 2006
NIBSC
whqlibdoc.who.int/hq/2008/WHO_BS_08.2092_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2092_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2092_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2092_eng.pdf Alpha-1-antitrypsin, extended u, Lyophilized, Total protein and
antigenic value of 12.4 mg. Potency of 243 nmoles for recombinant
AAT.
Human plasma05/16208.2092
1st International Standard, 2008NIBSC
Alphafoetoprotein, Lyophilized, 100,000 IU / ampoule.Human cord rum AFP
75.1121
1st International Standard, 1975NIBSC
whqlibdoc.who.int/hq/2007/WHO_BS_07.2073_eng.p df
whqlibdoc.who.int/hq/2007/WHO_BS_07.2073_eng.p df
whqlibdoc.who.int/hq/2007/WHO_BS_07.2073_eng.p df
whqlibdoc.who.int/hq/2007/WHO_BS_07.2073_eng.p df Amphotericin B, Lyophilized, 944 IU / mg. Approximately 100 mg of
Amphotericin B.
Antibiotic ISA_2907807.2073
2nd International Standard, 2007EDQM
Ancrod, Lyophilized, 55 IU/ampoule Enzyme74/58176.1130
1st International Reference
Preparation, 1976
NIBSC
Anthrax spore vaccine, Lyophilized spore suspension of Bacillus
anthracis strain 34 F2., 1 IU / ampoule.
Antigen AxV278.1198
1st International Reference
Preparation, 1978
NIBSC
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf Anti-A and anti-B antibodies in intravenous immunoglobulin: Limit
reference preparation, Lyophilized, Anti-A and anti-B titres in the 2-
fold range 32-64 using direct haemagglutination of A1 and B red cells.
Human immunoglobulin07/31008.2091
1st Reference Reagent, 2008NIBSC
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2091_eng.pdf Anti-A and anti-B antibodies in intravenous immunoglobulin: Positive
control and negative control for haemagglutination tests, Lyophilized.,
The guide titres for anti-A and anti-B in the Positive Control
preparation 07/306 are in the 2-fold ranges of 32-64 and 16-32,
respectively. 07/308 is the Negative Control in the same assays.
Human immunoglobulin07/306 &
07/308
08.2091
1st Reference Reagent, 2008NIBSC
www.who.int/bloodproducts/cs/062053antiaantib.pdf
www.who.int/bloodproducts/cs/062053antiaantib.pdf
www.who.int/bloodproducts/cs/062053antiaantib.pdf
www.who.int/bloodproducts/cs/062053antiaantib.pdf Anti-A blood grouping minimum potency reagent, Lyophilized, A 1 in 8
dilution defines the recommended minimum potency specification for
什么意思英语
anti-A blood grouping reagents.
Monoclonal IgM (murine)03/18806.2053
1st International Standard, 2005
NIBSC
Anti-B blood grouping minimum potency reagent, Lyophilized, A 1 in 4
dilution defines the recommended minimum potency specification for
anti-B blood grouping reagents.
Monoclonal IgM (murine)03/16405.2024
1st International Standard, 2005NIBSC
Anti-brucella abortus rum, bovine, Lyophilized, 1,000 IU / ampoule
of agglutinating; 1,000 IU / ampoule of complement-fixing activity.
Ovine rum
BaDS75.1124
2nd International Standard, 1975NIBSC
affliction
Anti-brucella ovis rum, ovine, Lyophilized, 1,000 IU / ampoule.Ovine rum BovisDs85.1485
1st International Standard, 1985NIBSC
Anti-C complete blood typing rum, Lyophilized, 100 IU/ampoule Human rum W100484.1424
1st International Standard, 1984NIBSC
Anti-c incomplete blood typing rum, Lyophilized, 64 IU/ampoule Human rum W100771.1038
1st International Standard, 1976NIBSC
Anti-canine distemper rum, Lyophilized, 1,000 IU / ampoule.Hor rum CDS67.881
chrisgardner
1st International Standard, 1967NIBSC
Anti-canine hepatitis rum, Lyophilized, 1,000 IU / ampoule.Hor rum CHS67.880
1st International Standard, 1967NIBSC
DOCUMENT
Anti-D (anti-Rho) minimum potency reagent, complete, Lyophilized, A
1 in 3 dilution defines the recommended minimum potency
specification for low protein anti-D blood reagents; a 1 in 8 dilution defines the recommended minimum potency specification for high protein anti-D reagents.
Monoclonal IgM (human)
99/836
04.2000 Rev. 1
1st International Standard, 2004
NIBSC
Anti-D antibodies in intravenous immunoglobulin: Positive control and
negative control for haemagglutination tests, Lyophilized., The guide titre for anti-D in the Positive Control preparation 02/228 is 8; 02/226 is the Negative Control in the same assay using direct haemagglutination of A1 and B red cells.
Human immunoglobulin 02/228 & 02/226
04.2002
1st Reference Reagent, 2004NIBSC
whqlibdoc.who.int/hq/2003/WHO_BS_03.962.pdf
whqlibdoc.who.int/hq/2003/WHO_BS_03.962.pdf whqlibdoc.who.int/hq/2003/WHO_BS_03.962.pdf whqlibdoc.who.int/hq/2003/WHO_BS_03.962.pdf Anti-D immunoglobulin, Lyophilized, 285 IU (57 µg)/ampoule
Human immunoglobulin
01/57203.19622nd International Standard, 2003
NIBSC whqlibdoc.who.int/hq/2005/WHO_BS_05.2009_eng.pdf
whqlibdoc.who.int/hq/2005/WHO_BS_05.2009_eng.pdf whqlibdoc.who.int/hq/2005/WHO_BS_05.2009_eng.pdf whqlibdoc.who.int/hq/2005/WHO_BS_05.2009_eng.pdf Anti-dengue virus type 1,2,3 and 4 rum, Freeze-dried, 100 units per rotype per ampoule.
Human plasma 02/18605.20091st Reference Reagent, 2005
NIBSC Anti-dyntery rum (Shiga), equine, , 1 IU equivalent to 0.05 mg of dried standard rum.
Hor rum DY Bull. Health Org. 4, 19351st International Standard, 1928
NIBSC Anti-E complete blood-typing rum, human, Lyophilized, 100 IU/ampoule.
Human rum W100583.14241st International Standard, 1983
NIBSC Anti-echinococcus rum, Lyophilized, 87.36 mg human rum/ampoule.
Human rum
ECHS 75.11061st International Reference Reagent, 1975
NIBSC Anti-hepatitis A immunoglobulin, Lyophilized, 49 IU/ampoule
Human immunoglobulin W1041
97/64698.18782nd International Standard, 1998NIBSC whqlibdoc.who.int/hq/2008/WHO_BS_08.2084_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2084_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2084_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2084_eng.pdf Anti-hepatitis B immunoglobulin, Lyophilized, 100 IU/ampoule
Human immunoglobulin 07/16408.2084
2nd International Standard, 2008
NIBSC whqlibdoc.who.int/hq/2008/WHO_BS_08.2098_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2098_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2098_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2098_eng.pdf Anti-hepatitis B virus core antibodies (anti-HBc), Lyophilized, 50 IU/vial Human plasma 95/52208.20981st International Standard, 2008NIBSC Anti-hepatitis E rum, Lyophilized, 50 units/ampoule
reactable
Human rum 95/58497.18691st Reference Reagent, 1997NIBSC Anti-HIV antibodies (HIV-1 subtypes A, B, C, CRF01,_AE, group O and HIV-2), Lyophilized, No unitage assigned.
Human plasma 02/21006.20321st International Reference Panel,
business travel2006
NIBSC whqlibdoc.who.int/hq/2011/WHO_BS_2011.2167_eng.pdf
whqlibdoc.who.int/hq/2011/WHO_BS_2011.2167_eng.pdf whqlibdoc.who.int/hq/2011/WHO_BS_2011.2167_eng.pdf whqlibdoc.who.int/hq/2011/WHO_BS_2011.2167_eng.pdf Anti-human neutrophil antigen-1a, Lyophilized, Minimum potency with 1 in 4 dilution
Human plasma 09/2842011.21671st International Reference Reagent, 2011
shunNIBSC whqlibdoc.who.int/hq/2005/WHO_BS_05.2011_eng.p df
whqlibdoc.who.int/hq/2005/WHO_BS_05.2011_eng.p df whqlibdoc.who.int/hq/2005/WHO_BS_05.2011_eng.p df whqlibdoc.who.int/hq/2005/WHO_BS_05.2011_eng.p df Anti-human platelet antigen 1 a (HPA-1 a), Lyophilized, 100 IU/ampoule
Human plasma 03/15205.2011
1st International Standard, 2005NIBSC www.who.int/biologicals/BS%202079%20HPA-1a.pdf
www.who.int/biologicals/BS%202079%20HPA-1a.pdf www.who.int/biologicals/BS%202079%20HPA-1a.pdf www.who.int/biologicals/BS%202079%20HPA-1a.pdf Anti-human platelet antigen 1 a (HPA-1 a) antibodies, Lyophilized, Minimum potency with 1 in 2 dilution
Human plasma 05/10607.2079
1st Reference Reagent, 2007NIBSC whqlibdoc.who.int/hq/2006/WHO_BS_06.2033_eng.pdf
whqlibdoc.who.int/hq/2006/WHO_BS_06.2033_eng.pdf whqlibdoc.who.int/hq/2006/WHO
_BS_06.2033_eng.pdf whqlibdoc.who.int/hq/2006/WHO_BS_06.2033_eng.pdf
Anti-human platelet antigen 3a (HPA-3a), Lyophilized, Minimum potency with 1 in 8 dilution
Human plasma 03/19006.20331st Reference Reagent, 2006NIBSC
Anti-human platelet antigen-5b (anti-HPA-5b), Lyophilized, Minimum potency with 1 in 2 dilution
Human plasma 99/56601.19451st Reference Reagent, 2003NIBSC Anti-interferon alpha rum, Lyophilized, 8,000 neutralising units/ampoule.
Human rum
G037-501-572root什么意思
94.1783
1st International Reference Reagent, 1994
NIAID
DOCUMENT
Anti-interferon beta rum, Lyophilized, 1,500 neutralising
units/ampoule
Human rum G038-501-57294.17831st International Reference Reagent, 1994
NIAID
whqlibdoc.who.int/hq/2007/WHO_BS_07.2076_eng.p df
whqlibdoc.who.int/hq/2007/WHO_BS_07.2076_eng.p df whqlibdoc.who.int/hq/2007/WHO_BS_07.2076_eng.p df whqlibdoc.who.int/hq/2007/WHO_BS_07.2076_eng.p df Anti-measles rum, Lyophilized, 3 IU/
ampoule
Human rum 97/648 07.2076, 06.20313rd International Standard, 2006NIBSC Anti-mycoplasma gallipticum rum, Lyophilized, 1,000 IU /
ampoule of agglutinating activity and 1,000 IU / ampoule of haemagglutination-inhibiting activity.
Chicken rum
MgDS
69.961
1st International Reference Preparation, 1969
NIBSC
Anti-newcastle-dia rum, Lyophilized, 320 IU / ampoule.Chicken rum NDS 67.8781st International Reference Preparation, 1968
NIBSC Anti-nuclear ribonucleoprotein rum, Lyophilized, No unitage assigned.
Human rum W106383.13901st International Reference Reagent, 1983
NIBSC Anti-nuclear-factor (homogeneous) rum, Lyophilized, 100 IU/ampoule
Human rum 66/233 (W1064)70.10051st International Reference Preparation, 1970
NIBSC
whqlibdoc.who.int/hq/2003/WHO_BS_03.960.pdf
whqlibdoc.who.int/hq/2003/WHO_BS_03.960.pdf whqlibdoc.who.int/hq/2003/WHO_BS_03.960.pdf whqlibdoc.who.int/hq/2003/WHO_BS_03.960.pdf Anti-parvovirus B19 (IgG) rum, Lyophilized,
77 IU/ampoule Human rum 01/60203.19602nd International Standard, 2003NIBSC Anti-pertussis rum, mou, Lyophilized, 17 units / vial of anti-pertussis toxin. 143 units / vial of anti-filamentous haemagglutinin. 30 units / vial of anti-pertactin. 32 units / vial of anti-fimbria types 2/3.Mou rum
97/642
99.1901
1st Reference Reagent, 1999
NIBSC
whqlibdoc.who.int/hq/2006/WHO_BS_06.2038_eng.pdf
whqlibdoc.who.int/hq/2006/WHO_BS_06.2038_eng.pdf whqlibdoc.who.int/hq/2006/WHO_BS_06.2038_eng.pdf whqlibdoc.who.int/hq/2006/WHO_BS_06.2038_eng.pdf Anti-poliovirus rum (Types 1, 2, 3), Lyophilized, 11 IU/ampoule (Type 1), 32 IU/ampoule (Type 2), 3 IU/ampoule (Type 3)Human rum 8
2/58506.20383rd International Standard, 2006NIBSC Anti-Q-fever rum, bovine, Lyophilized, 1,000 IU / ampoule.Bovine rum
QF 53.2301st International Standard, 1954NIBSC
Anti-rabies immunoglobulin, Lyophilized, 30 IU/ampoule Human immunoglobulin RAI 93.17492nd International Standard, 1993NIBSC Anti-rubella immunoglobulin, Lyophilized, 1,600 IU/vial
Human immunoglobulin RUBI-1-9496.18331st International Standard, 1996NIBSC Anti-salmonella pullorum rum (Standard Form S), Lyophilized, 1,000 IU/ampoule
Goat rum SpDS-S273.10661st International Standard, 1973NIBSC Anti-salmonella pullorum rum (Variant Form V), Lyophilized, 1,000 IU / ampoule.
Goat rum SpDS-V 73.10661st International Standard, 1973NIBSC Anti-smooth muscle rum, Lyophilized, No unitage assigned.
Human rum W106283.13901st International Reference
Reagent, 1983
NIBSC Anti-staphylococcal P-V leucocidin rum, equine, Lyophilized, 150 IU / ampoule.
Hor rum SPLS 65.7691st International Standard, 1965NIBSC Anti-swine fever rum, Lyophilized, 1,000 IU / ampoule.
Pig rum SFS 62.5731st International Standard, 1963NIBSC
http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf
http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf Anti-syphilitic plasma IgG, Lyophilized, 0.3 IU per ampoule relative to 05/132 the 1st IS for human syphilitic plasma IgG and IgM.Human plasma 05/12207.20592nd International Standard, 2007NIBS
C http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf
http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf http:/www.who.int/biologicals/expert_committee/BS%202059%20syphilitic%20antibodies.pdf Anti-syphilitic plasma IgG and IgM, Lyophilized, 3 IU/ampoule Human plasma 05/13207.20591st International Standard, 2007NIBSC Anti-tetanus immunoglobulin, Lyophilized, 120 IU/ampoule.
Human immunoglobulin
TE-3
92.1696
1st International Standard, 1992
NIBSC
DOCUMENT
whqlibdoc.who.int/hq/2010/WHO_BS_10.2146_eng.pdf
英翻汉在线翻译whqlibdoc.who.int/hq/2010/WHO_BS_10.2146_eng.pdf whqlibdoc.who.int/hq/2010/WHO_BS_10.2146_eng.pdf whqlibdoc.who.int/hq/2010/WHO_BS_10.2146_eng.pdf Antithrombin, Lyophilized, Functional potency - 0.95 IU/ampoule, Antigenic potency - 0.96 IU/ampoule
Human plasma 08/25810.21463rd International Standard, 2010NIBSC
发挥英文
www.who.int/biologicals/BS%202069%20Antithrombin.pdf
www.who.int/biologicals/BS%202069%20Antithrombin.pdf www.who.int/biologicals/BS%202069%20Antithrombin.pdf www.who.int/biologicals/BS%202069%20Antithrombin.pdf Antithrombin, concentrate, Lyophiliz
ed, Functional potency - 4.4 IU/ampoule. Antigenic potency - 4.5 IU/ampoule.Purified plasma protein 06/16607.20693rd International Standard, 2007NIBSC Anti-thyroglobulin rum, Lyophilized, 1,000 IU/ampoule Human rum 65/09378.11881st International Reference
Preparation, 1978
NIBSC Anti-tick borne encephalitis rum (louping ill (Moredun) virus), Lyophilized, No unitage assigned.
Sheep rum TILI 64.7071st International Reference Reagent, 1964
NIBSC Anti-tick borne encephalitis rum (Russian spring-summer (sophyn and abttarov virus), Lyophilized, No unitage assigned.Sheep rum TISA 64.7071st International Reference Reagent, 1964
NIBSC Anti-toxoplasma rum, Lyophilized, 1,000 IU/ampoule.Human rum TOXM 94.17613rd International Standard, 1994NIBSC
whqlibdoc.who.int/hq/2003/WHO_BS_03.1971.pdf whqlibdoc.who.int/hq/2003/WHO_BS_03.1971.pdf whqlibdoc.who.int/hq/2003/WHO_BS_03.1971.pdf whqlibdoc.who.int/hq/2003/WHO_BS_03.1971.pdf Anti-toxoplasma rum (IgG), Lyophilized, 20 IU / ampoule.Human rum 01/60003.19711st International Standard, 2003NIBSC Anti-Trypanosoma cruzi I antibody (TcI), Lyophilized, 1 IU/ml Human plasma 09/1862011.21811st International Standard, 2011NIBSC Anti-Trypanozoma cruzi II antibody (TcII), Lyophilized, 1 IU/ml Human plasma 09/1882011.21811st International Standard, 2011NIBSC Anti-varicella zoster immunoglobulin, Lyophilized, 50 IU/ampoule Human immunoglobulin W104487.15651st International Standard, 1987NIBSC
Anti-yellow fever rum, monkey, Lyophilized, 143 IU / ampoule.Monkey rum YF 62.5451st International Standard, 1962NIBSC Apolipoprotein A-1, Lyophilized, 1.5 mg/vial.Human rum SP1-0192.17061st International Reference Reagent, 1992
CDC Apolipoprotein B, Frozen, 1.22 mg/vial.
Human rum SP3-0793.17211st International Reference Reagent, 1993
CDC Arginine vasopressin, Lyophilized, 8.2 IU / ampoule.
Hormone 77/50178.12311st International Standard, 1978NIBSC Atrial natriuretic factor, human, Lyophilized, 2.5 IU / ampoule.Peptide hormone 85/66987.15781st International Standard, 1987NIBSC Bacitracin, Lyophilized, Approximately 100 mg of zinc bacitracin (74 IU / mg).
Antibiotic
62/00364.6812nd International Standard, 1964EDQM Basic fibroblast growth factor (bFGF, FGF-2), human, rDNA derived, Lyophilized, 1,600 IU / ampoule.
Recombinant growth factor 90/71293.17361st International Standard, 1993NIBSC BCG vaccine, Lyophilized, 2.5 mg of mi-dry bacillary mass / 5-ml ampoule.
Antigen BCG 65.8021st International Reference Preparation, 1965
NIBSC
/hq/2009/WHO_BS_09.2114_eng.p df /hq/2009/WHO_BS_09.2114_eng.p df /hq/2009/WHO_BS_09.2114_eng.p df /hq/2009/WHO_BS_09.2114_eng.p df BCG, Danish 1331 sub-strain for viability, identity and in vivo assays, Lyophilized,
Bacteria 07/27009.21141st Reference Reagent, 2009NIBSC
whqlibdoc.who.int/hq/2010/WHO_BS_10.2148_eng.pdf
whqlibdoc.who.int/hq/2010/WHO_BS_10.2148_eng.pdf whqlibdoc.who.int/hq/2010/WHO_BS_10.2148_eng.pdf whqlibdoc.who.int/hq/2010/WHO_BS_10.2148_eng.pdf BCG, Russian BCG-I sub-strain for viability, identity and in vivo assays, Lyophilized,
Bacteria 07/27410.2148, 09.21141st Reference Reagent, 2010NIBSC
/hq/2009/WHO_BS_09.2114_eng.p df
/hq/2009/WHO_BS_09.2114_eng.p df /hq/2009/WHO_BS_09.2114_eng.p df /hq/2009/WHO_BS_09.2114_eng.p df BCG, Tokyo 172 sub-strain for viability, identity and in vivo assays, Lyophilized,
Bacteria
07/27209.21141st Reference Reagent, 2009NIBSC
whqlibdoc.who.int/hq/2009/WHO_BS_09.2106_eng.pdf
whqlibdoc.who.int/hq/2009/WHO_BS_09.2106_eng.pdf whqlibdoc.who.int/hq/2009/WHO_BS_09.2106_eng.pdf whqlibdoc.who.int/hq/2009/WHO_BS_09.2106_eng.pdf BCR-ABL translocation, four panel members Lyophilized 10%, 1%, 0.1% & 0.01%, ,
Freeze-dried cells
09/138
09.2106
1st Reference Panel, 2009
NIBSC
DOCUMENT
Beta-2 microglobulin, Lyophilized, 100 IU / ampoule.Human rum
B2M 85.15011st International Standard, 1985NIBSC Beta-thromboglobulin, Lyophilized, 500 IU/ampoule.
Purified plasma protein 83/50184.14551st International Standard, 1984NIBSC Birch pollen extract (Betula verrucosa), Lyophilized, 100,000 IU / ampoule.
Allergen 84/52286.15121st International Standard, 1986
NIBSC Bleomycin complex A2/B2, Lyophilized, 8,910 IU / ampoule.Antibiotic
78/54780.12761st International Reference Preparation, 1980
EDQM whqlibdoc.who.int/hq/2008/WHO_BS_08.2097_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2097_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2097_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2097_eng.pdf Blood coagulation factor IX concentrate, Lyophilized, 7.9 IU/vial.Purified plasma protein 07/18208.20974th International Standard, 2008
NIBSC Blood coagulation factor IXa, concentrate, Lyophilized, 11.0 IU/ampoule.
Recombinant protein 97/56299.19161st International Standard, 1999NIBSC www.who.int/bloodproducts/publications/05-2007%20BCF%20V%20in%20plasma.pdf
www.who.int/bloodproducts/publications/05-2007%20BCF%20V%20in%20plasma.pdf www.who.int/bloodproducts/publications/05-2007%20BCF%20V%20in%20plasma.pdf www.who.int/bloodproducts/publications/05-2007%20BCF%20V%20in%20plasma.pdf Blood coagulation factor V, Lyophilized, 0.74 IU of Factor V:C per ampoule
Human plasma 03/11605.20071st International Standard, 2005NIBSC http:/www.who.int/bloodproducts/cs/en/041997.pdf
http:/www.who.int/bloodproducts/cs/en/041997.pdf http:/www.who.int/bloodproducts/cs/en/041997.pdf
http:
/www.who.int/bloodproducts/cs/en/041997.pdf Blood coagulation factor V Leiden (G1691A), human gDNA (three samples: FV wild type; FVL homozygote; FVL heterozygote), Lyophilized, No assigned value
Genetic material
04/224
04.1997
1st International Reference Panel, 2004
NIBSC
www.who.int/iris/bitstream/10665/78045/1/WHO_BS_2012.2204_eng.pdf
www.who.int/iris/bitstream/10665/78045/1/WHO_BS_2012.2204_eng.pdf
www.who.int/iris/bitstream/10665/78045/1/WHO_BS_2012.2204_eng.pdf www.who.int/iris/bitstream/10665/78045/1/WHO_BS_2012.2204_eng.pdf Blood coagulation fa
ctor VII, concentrate, Lyophilized, Chromogenic method: 9.8 IU/ampoule; Clotting method: 10.6 IU/ampoule
Purified plasma protein 10/2522012.22042nd International Standard, 2012
NIBSC whqlibdoc.who.int/hq/2008/WHO_BS_08.2090_eng.pdf
whqlibdoc.who.int/hq/2008/WHO_BS_08.2090_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2090_eng.pdf whqlibdoc.who.int/hq/2008/WHO_BS_08.2090_eng.pdf Blood coagulation factor VIIa concentrate, human, Lyophilized, 656 IU / ampoule.
Recombinant protein 07/22808.20902nd International Standard, 2008
NIBSC whqlibdoc.who.int/hq/2009/WHO_BS_09.2116_eng.p df
whqlibdoc.who.int/hq/2009/WHO_BS_09.2116_eng.p df whqlibdoc.who.int/hq/2009/WHO_BS_09.2116_eng.p df whqlibdoc.who.int/hq/2009/WHO_BS_09.2116_eng.p df Blood coagulation factor VIII and von Willebrand factor, Lyophilized,
Factor VIII: C 0.68 IU/ amp; Factor VIII:Antigen 1.04 IU/ amp;
VWF:Antigen 1.00 IU/ amp; VWF:Ristocetin cofactor 0.87 IU/amp; VWF:Collagen binding 1.03 IU/amp; VWFpp 1.03 IU/amp Human plasma
07/316
09.2116; 2011.2171
6th International Standard, 2009 / VWFpp 2011
NIBSC
whqlibdoc.who.int/hq/2009/WHO_BS_09.2117_eng.pdf
whqlibdoc.who.int/hq/2009/WHO_BS_09.2117_eng.pdf whqlibdoc.who.int/hq/2009/WHO_BS_09.2117_eng.pdf whqlibdoc.who.int/hq/2009/WHO_BS_09.2117_eng.pdf Blood coagulation factor VIII, concentrate, Lyophilized., 9.4 IU/ampoule
Purified plasma protein 07/350
09.21178th International Standard, 2009NIBSC /bloodproducts/cs/052017.pdf
/bloodproducts/cs/052017.pdf /bloodproducts/cs/052017.pdf
/bloodproducts/cs/052017.pdf Blood coagulation factor XI, Lyophilized, 0.86 IU/ampoule Human plasma 04/10205.20171st International Standard, 2005NIBSC www.who.int/iris/bitstream/10665/78047/1/WHO_BS_2012.2206_eng.pdf
www.who.int/iris/bitstream/10665/78047/1/WHO_BS_2012.2206_eng.pdf www.who.int/iris/bitstream/10665/78047/1/WHO_BS_2012.2206_eng.pdf www.who.int/iris/bitstream/10665/78047/1/WHO_BS_2012.2206_eng.pdf Blood coagulation factor XI activated (FXIa), Lyophilized, 10 units/ampoule.
Human plasma 11/2362012.22061st International Reference Reagent, 2012
NIBSC Blood coagulation factor XIII, Lyophilized, Activity 0.91 IU/ampoule; Antigen 0.93 IU/ampoule
Human plasma
02/20604.1994 Rev.11st International Standard, 2004NIBSC www.who.int/iris/bitstream/10665/78051/1/WHO_BS_2012.2210_eng.pdf
www.who.int/iris/bitstream/10665/78051/1/WHO_BS_2012.2210_eng.pdf
www.who.int/iris/bitstream/10665/78051/1/WHO_BS_2012.2210_eng.pdf www.who.int/iris/bitstream/10665/78051/1/WHO_BS_2012.2210_eng.pdf Blood coagulation factors II and X, concentrate, Lyophilized, FII: 9.4 IU/ampoule, FX: 8.1 IU/ampoule
Purified plasma proteins 11/1262012.22104th International Standard, 2012NIBSC whqlibdoc.who.int/hq/2010/WHO_BS_10.2145_eng.pdf
whqlibdoc.who.int/hq/2010/WHO_BS_10.2145_eng.pdf whqlibdoc.who.int/hq/2010/WHO_BS_10.2145_eng.pdf whqlibdoc.who.int/hq/2010/WHO_BS_10.2145_eng.pdf Blood coagulation factors II, VII, IX, X, Lyophilized, 0.89 IU (factor II), 0.99 IU (factor VII), 0.86 IU (factor IX), 0.89 IU (factor X) / ampoule.Human plasma 09/17210.21454th International Standard, 2010
NIBSC Bone morphogenic protein-2, human, rDNA derived, Lyophilized, 5,000 units / ampoule.
Recombinant cytokine 93/57497.18571st Reference Reagent, 1997NIBSC whqlibdoc.who.int/hq/2009/WHO_BS_09.2120_eng.pdf
whqlibdoc.who.int/hq/2009/WHO_BS_09.2120_eng.pdf whqlibdoc.who.int/hq/2009/WHO_BS_09.2120_eng.pdf whqlibdoc.who.int/hq/2009/WHO
_BS_09.2120_eng.pdf Bordetella pertussis fimbrial antigen type 2 (monoclonal antibody for rotyping). Lyophilized. No assigned values, ,
Cell culture suspension
06/124
09.2120
1st International Standard, 2009
NIBSC
各国第一夫人
